{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:55:16Z","timestamp":1788501316780,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mackenzie Charitable Foundation"},{"DOI":"10.13039\/100008247","name":"University of Otago","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008247","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.freeradbiomed.2016.08.027","type":"journal-article","created":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T08:59:09Z","timestamp":1472461149000},"page":"451-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice"],"prefix":"10.1016","volume":"99","author":[{"given":"Elizabeth J.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet C.M.","family":"Vissers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wohlrab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin O.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Matthew","family":"Strother","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Bozonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabi U.","family":"Dachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.freeradbiomed.2016.08.027_bib1","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1073\/pnas.73.10.3685","article-title":"Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer","volume":"73","author":"Cameron","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2016.08.027_bib2","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1073\/pnas.75.9.4538","article-title":"Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer","volume":"75","author":"Cameron","year":"1978","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"38","key":"10.1016\/j.freeradbiomed.2016.08.027_bib3","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"13","key":"10.1016\/j.freeradbiomed.2016.08.027_bib4","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1158\/0008-5472.CAN-06-3884","article-title":"Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy","volume":"67","author":"Ohtani","year":"2007","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.08.027_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.freeradbiomed.2009.02.016","article-title":"Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects","volume":"47","author":"Verrax","year":"2009","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.08.027_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ajco.12173","article-title":"Review of high-dose intravenous vitamin C as an anticancer agent","volume":"10","author":"Wilson","year":"2014","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2016.08.027_bib7","doi-asserted-by":"crossref","first-page":"e11414","DOI":"10.1371\/journal.pone.0011414","article-title":"Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects","volume":"5","author":"Padayatty","year":"2010","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.freeradbiomed.2016.08.027_bib8","doi-asserted-by":"crossref","first-page":"11105","DOI":"10.1073\/pnas.0804226105","article-title":"Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice","volume":"105","author":"Chen","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.08.027_bib9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ccr.2007.08.004","article-title":"HIF-dependent antitumorigenic effect of antioxidants in vivo","volume":"12","author":"Gao","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fonc.2014.00356","article-title":"Pharmacological doses of daily ascorbate protect tumors from radiation damage after a single dose of radiation in an intracranial mouse glioma model","volume":"4","author":"Grasso","year":"2014","journal-title":"Front. Oncol."},{"issue":"6266","key":"10.1016\/j.freeradbiomed.2016.08.027_bib11","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.08.027_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1634\/theoncologist.2014-0381","article-title":"Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review","volume":"20","author":"Jacobs","year":"2015","journal-title":"Oncologist"},{"issue":"222","key":"10.1016\/j.freeradbiomed.2016.08.027_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.08.027_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00280-013-2179-9","article-title":"Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer","volume":"72","author":"Stephenson","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.08.027_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/cr.2016.7","article-title":"Anti-cancer effects of vitamin C revisited","volume":"26","author":"van der Reest","year":"2016","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.08.027_bib16","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00280-013-2070-8","article-title":"Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial","volume":"71","author":"Welsh","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"21","key":"10.1016\/j.freeradbiomed.2016.08.027_bib17","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.1073\/pnas.0702854104","article-title":"Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo","volume":"104","author":"Chen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.08.027_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1158\/1078-0432.CCR-09-1713","article-title":"Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer","volume":"16","author":"Du","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib19","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.freeradbiomed.2014.01.033","article-title":"Intracellular ascorbate enhances hypoxia-inducible factor (HIF)-hydroxylase activity and preferentially suppresses the HIF-1 transcriptional response","volume":"69","author":"Kuiper","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3389\/fonc.2014.00359","article-title":"Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression","volume":"4","author":"Kuiper","year":"2014","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.08.027_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nchembio863","article-title":"Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one?","volume":"3","author":"Ozer","year":"2007","journal-title":"Nat. Chem. Biol."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2016.08.027_bib22","first-page":"1764","article-title":"Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells","volume":"63","author":"Knowles","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fonc.2014.00010","article-title":"Increased tumor ascorbate is associated with extended disease-free survival and decreased hypoxia-inducible factor-1 activation in human colorectal cancer","volume":"4","author":"Kuiper","year":"2014","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.08.027_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.freeradbiomed.2006.11.023","article-title":"Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate","volume":"42","author":"Vissers","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib25","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","article-title":"Hypoxia inducible factor-1 modulates gene expression in solid tumours and influences both angiogenesis and tumour growth","volume":"94","author":"Maxwell","year":"1997","journal-title":"Proc. Nat. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.freeradbiomed.2016.08.027_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2016.08.027_bib27","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1172\/JCI67230","article-title":"HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations","volume":"123","author":"Semenza","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"16","key":"10.1016\/j.freeradbiomed.2016.08.027_bib28","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","article-title":"HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia","volume":"22","author":"Berra","year":"2003","journal-title":"EMBO J."},{"issue":"6733","key":"10.1016\/j.freeradbiomed.2016.08.027_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/9780470035009.ch3","article-title":"Regulation of HIF: prolyl hydroxylases","volume":"272","author":"Stolze","year":"2006","journal-title":"Novartis Found. Symp."},{"issue":"P5918","key":"10.1016\/j.freeradbiomed.2016.08.027_bib31","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1113\/jphysiol.2013.251470","article-title":"Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer","volume":"591","author":"Ratcliffe","year":"2013","journal-title":"J. Physiol."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2016.08.027_bib32","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1073\/pnas.93.8.3704","article-title":"Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance","volume":"93","author":"Levine","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.freeradbiomed.2016.08.027_bib33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-140-7-200404060-00010","article-title":"Vitamin C pharmacokinetics: implications for oral and intravenous use","volume":"140","author":"Padayatty","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib34","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.freeradbiomed.2014.09.023","article-title":"Pharmacokinetic modeling of ascorbate diffusion through normal and tumor tissue","volume":"77","author":"Kuiper","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/j.1476-5381.2011.01350.x","article-title":"The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C","volume":"164","author":"May","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib36","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.3390\/nu5082860","article-title":"Regulation of vitamin C homeostasis during deficiency","volume":"5","author":"Lindblad","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib37","first-page":"e006979","article-title":"Identification of vitamin C transporters in the human airways: a cross-sectional in vivo study","author":"Larsson","year":"2015","journal-title":"Br. Med. J. Open"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.08.027_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1073\/pnas.97.2.841","article-title":"Aortic wall damage in mice unable to synthesize ascorbic acid","volume":"97","author":"Maeda","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.08.027_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cam4.349","article-title":"Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo-\/- mice","volume":"4","author":"Campbell","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib40","first-page":"41","article-title":"Ascorbate availability affects tumor implantation-take rate and increases tumor rejection in Gulo-\/- mice","volume":"4","author":"Campbell","year":"2016","journal-title":"Hypoxia"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.08.027_bib41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3945\/ajcn.110.004853","article-title":"Dietary ascorbate intake affects steady state tissue concentrations in vitamin C-deficient mice: tissue deficiency after suboptimal intake and superior bioavailability from a food source (kiwifruit)","volume":"93","author":"Vissers","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1042\/bj3060101","article-title":"Analysis of water-soluble antioxidants by high-pressure liquid chromatography","volume":"306","author":"Rose","year":"1995","journal-title":"Biochem. J."},{"issue":"14","key":"10.1016\/j.freeradbiomed.2016.08.027_bib43","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1158\/0008-5472.CAN-10-0263","article-title":"Low ascorbate levels are associated with increased hypoxia-inducible factor-1 activity and an aggressive tumor phenotype in endometrial cancer","volume":"70","author":"Kuiper","year":"2010","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.08.027_bib44","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bbrc.2011.09.146","article-title":"Differential regulation of the ascorbic acid transporter SVCT2 during development and in response to ascorbic acid depletion","volume":"414","author":"Meredith","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.08.027_bib45","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/his.12678","article-title":"Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients","volume":"67","author":"Gerring","year":"2015","journal-title":"Histopathology"},{"issue":"14","key":"10.1016\/j.freeradbiomed.2016.08.027_bib46","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0959-8049(96)00379-6","article-title":"Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation","volume":"32","author":"Vermeulen","year":"1996","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.08.027_bib47","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput. Methods Prog. Biomed."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.08.027_bib48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0304-3835(80)90130-5","article-title":"Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture","volume":"11","author":"Bertram","year":"1980","journal-title":"Cancer Lett."},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s002800050773","article-title":"Paclitaxel\/carboplatin administration alongwith antiangiogenic therapy in nonsmall-cell lung and breast carcinoma models","volume":"41","author":"Herbst","year":"1998","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.08.027_bib50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/bcpt.12323","article-title":"Elimination of ascorbic acid after high-dose infusion in prostate cancer patients: a pharmacokinetic evaluation","volume":"116","author":"Nielsen","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00726-007-0555-7","article-title":"SVCT1 and SVCT2: key proteins for vitamin C uptake","volume":"34","author":"Savini","year":"2008","journal-title":"Amino Acids"},{"key":"10.1016\/j.freeradbiomed.2016.08.027_bib52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jemt.20255","article-title":"Immunohistochemical study on the distribution of sodium-dependent vitamin C transporters in the respiratory system of adult rat","volume":"68","author":"Jin","year":"2005","journal-title":"Microsc. Res Tech."},{"issue":"11","key":"10.1016\/j.freeradbiomed.2016.08.027_bib53","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/0006-2952(90)90086-Z","article-title":"Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules","volume":"40","author":"Raleigh","year":"1990","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.08.027_bib54","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/0006-291X(76)91046-9","article-title":"The catalytic effect of the carcinogen \"4-nitroquinoline-N-oxide\" on the oxidation of vitamin C","volume":"70","author":"Biaglow","year":"1976","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4\u20135","key":"10.1016\/j.freeradbiomed.2016.08.027_bib55","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1751-1097.1978.tb07034.x","article-title":"The oxidation of ascorbate by electron affinic drugs and carcinogens","volume":"28","author":"Biaglow","year":"1978","journal-title":"Photochem. Photobiol."},{"issue":"2\u20133","key":"10.1016\/j.freeradbiomed.2016.08.027_bib56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mvr.2007.05.003","article-title":"Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization","volume":"74","author":"Fukumura","year":"2007","journal-title":"Microvasc. Res."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916304087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916304087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:38:31Z","timestamp":1760204311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584916304087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":56,"alternative-id":["S0891584916304087"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.08.027","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}